These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Fibroblast growth factor 21 corrects obesity in mice. Coskun T; Bina HA; Schneider MA; Dunbar JD; Hu CC; Chen Y; Moller DE; Kharitonenkov A Endocrinology; 2008 Dec; 149(12):6018-27. PubMed ID: 18687777 [TBL] [Abstract][Full Text] [Related]
27. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders. Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050 [TBL] [Abstract][Full Text] [Related]
28. Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice. Maekawa R; Seino Y; Ogata H; Murase M; Iida A; Hosokawa K; Joo E; Harada N; Tsunekawa S; Hamada Y; Oiso Y; Inagaki N; Hayashi Y; Arima H J Nutr Biochem; 2017 Nov; 49():71-79. PubMed ID: 28886439 [TBL] [Abstract][Full Text] [Related]
29. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Fisher FM; Chui PC; Antonellis PJ; Bina HA; Kharitonenkov A; Flier JS; Maratos-Flier E Diabetes; 2010 Nov; 59(11):2781-9. PubMed ID: 20682689 [TBL] [Abstract][Full Text] [Related]
30. Relationship between FGF21 and UCP1 levels under time-restricted feeding and high-fat diet. Chapnik N; Genzer Y; Froy O J Nutr Biochem; 2017 Feb; 40():116-121. PubMed ID: 27883936 [TBL] [Abstract][Full Text] [Related]
31. Purified Betacyanins from Hylocereus undatus Peel Ameliorate Obesity and Insulin Resistance in High-Fat-Diet-Fed Mice. Song H; Chu Q; Xu D; Xu Y; Zheng X J Agric Food Chem; 2016 Jan; 64(1):236-44. PubMed ID: 26653843 [TBL] [Abstract][Full Text] [Related]
32. Dietary induction of obesity and insulin resistance is associated with changes in Fgf21 DNA methylation in liver of mice. Geißler C; Krause C; Neumann AM; Britsemmer JH; Taege N; Grohs M; Kaehler M; Cascorbi I; Lewis AG; Seeley RJ; Oster H; Kirchner H J Nutr Biochem; 2022 Feb; 100():108907. PubMed ID: 34801693 [TBL] [Abstract][Full Text] [Related]
34. FGF21 decreases body weight without reducing food intake or bone mineral density in high-fat fed obese rhesus macaque monkeys. Andersen B; Straarup EM; Heppner KM; Takahashi DL; Raffaele V; Dissen GA; Lewandowski K; Bödvarsdottir TB; Raun K; Grove KL; Kievit P Int J Obes (Lond); 2018 Jun; 42(6):1151-1160. PubMed ID: 29892039 [TBL] [Abstract][Full Text] [Related]
35. [Therapeutic effect of fibroblast growth factor 21 on NAFLD in MSG-iR mice and its mechanism]. Zhu SL; Zhang ZY; Ren GP; Ye XL; Ma L; Yu D; Han MM; Zhao JZ; Zhang TY; Li DS Yao Xue Xue Bao; 2013 Dec; 48(12):1778-84. PubMed ID: 24689234 [TBL] [Abstract][Full Text] [Related]
36. Fgf21 impairs adipocyte insulin sensitivity in mice fed a low-carbohydrate, high-fat ketogenic diet. Murata Y; Nishio K; Mochiyama T; Konishi M; Shimada M; Ohta H; Itoh N PLoS One; 2013; 8(7):e69330. PubMed ID: 23874946 [TBL] [Abstract][Full Text] [Related]
37. Interplay between FGF21 and insulin action in the liver regulates metabolism. Emanuelli B; Vienberg SG; Smyth G; Cheng C; Stanford KI; Arumugam M; Michael MD; Adams AC; Kharitonenkov A; Kahn CR J Clin Invest; 2014 Feb; 124(2):515-27. PubMed ID: 24401271 [TBL] [Abstract][Full Text] [Related]
38. Whey protein isolate inhibits hepatic FGF21 production, which precedes weight gain, hyperinsulinemia and hyperglycemia in mice fed a high-fat diet. Nonogaki K; Kaji T Sci Rep; 2020 Sep; 10(1):15784. PubMed ID: 32978487 [TBL] [Abstract][Full Text] [Related]
39. FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes. Laeger T; Baumeier C; Wilhelmi I; Würfel J; Kamitz A; Schürmann A Diabetologia; 2017 Nov; 60(11):2274-2284. PubMed ID: 28770320 [TBL] [Abstract][Full Text] [Related]
40. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Dushay J; Chui PC; Gopalakrishnan GS; Varela-Rey M; Crawley M; Fisher FM; Badman MK; Martinez-Chantar ML; Maratos-Flier E Gastroenterology; 2010 Aug; 139(2):456-63. PubMed ID: 20451522 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]